Digestive System Ulcerative Colitis

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
Ulcerative Colitis Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Ulcerative Colitis Projects
--Alizyme plc
--Abbott Laboratories
--Bristol-Myers Squibb Company
--AM-Pharma B.V.
--Cerimon Pharmaceuticals, Inc.
--Centocor, Inc.
--Genentech Inc
--Cosmo Pharmaceuticals S.p.A.
--InDex Pharmaceuticals AB
--Hollis-Eden Pharmaceuticals Inc
--Johnson & Johnson
--Isis Pharmaceuticals Inc
--Otsuka America Pharmaceutical, Inc.
--Ocera Therapeutics, Inc.
--Pfizer Inc
--Otsuka Pharmaceutical Co., Ltd.
--Schering-Plough Corp
--Prometheus Laboratories, Inc.
--Zeria Pharmaceutical Co., Ltd.
--Synvista Therapeutics, Inc.

--Top Companies in early stage Ulcerative Colitis Projects
--AGI Therapeutics plc
--ActoGeniX NV
--BTG plc
--Asphelia Pharmaceuticals, Inc.
--China Medical System Holdings Limited
--ChemoCentryx, Inc.
--LTT Bio-Pharma Co., Ltd
--Inotek Pharmaceuticals, Inc
--Nucryst Pharmaceuticals Corp
--Medarex Inc
--Resolvyx Pharmaceuticals, Inc.
--PALAU PHARMA
--S.L.A. Pharma AG
--Roche Holdings Ltd

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View